Kettering General Hospital
NHS Foundation Trust
 
back
11 Eye
11-08-02 Subfoveal choroidal neovascularisation

Brolucizumab Boevu®
Restricted

Intravitreal 19.8 mg brolucizumab in 0.165 ml solution

 

Link  Brolucizumab for treating wet age-related macular degeneration
Link  
 

Restricted Drug Red View adult BNF  View SPC online  View childrens BNF
Ranibizumab Lucentis®
Restricted

Intravitreal injection 2.3mg/0.23ml (10mg/ml)

Link  NICE TA274: Macular oedema (diabetic)
Link  NICE TA283: Macular oedema (retinal vein occlusion)
Link  NICE TA298: Choroidal neovascularisation (pathological myopia)
 

Restricted Drug View adult BNF  View SPC online  View childrens BNF  HCD
Bevacizumab Avastin®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Pegaptanib Sodium Macugen®
Non Formulary

View adult BNF  View SPC online  View childrens BNF
Verteporfin Visudyne®
Non Formulary

View adult BNF  View SPC online  View childrens BNF